Feldan Therapeutics Secures $16.5M Series B To Bring Lead Asset To Clinical Development
Amount Raised
$16.5 Million
Round Type
Series B
Quebec CityBiotechnologyHealth CareScience And EngineeringInvestors
Description
Feldan Therapeutics, a biopharmaceutical company that specializes in the development of treatments based on intracellular delivery of therapeutics, has announced the initial closing of a $16.5 million Series B investment. The funds will primarily be used to conduct clinical phases I/II for Feldan's FLD-103, an intralesional treatment against basal cell carcinoma (BCC), and to advance its pulmonary program to the preclinical stage.
Quick answer
Feldan Therapeutics raised $16.5 Million in a Series B round, dated June 13, 2023. Investors: Fsit2, Gc Cell, Amgen Ventures and Investissement Québec. Feldan Therapeutics is based in Quebec City, Quebec, Canada.
- How much did Feldan Therapeutics raise?
- Feldan Therapeutics raised $16.5 Million in a Series B round on June 13, 2023.
- Who invested in Feldan Therapeutics?
- Fsit2, Gc Cell, Amgen Ventures and Investissement Québec are named as investors in this round.
- What does Feldan Therapeutics do?
- Feldan is a biopharmaceutical company that specializes in the development of treatments based on the intracellular delivery of therapeutics.
- Where is Feldan Therapeutics based and how big is it?
- Feldan Therapeutics is based in Quebec City, Quebec, Canada.
- Who are the decision-makers at Feldan Therapeutics?
- Fundz holds 1 contact at Feldan Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Science And Engineering and Biotechnology around the same time
Companies in the same sectors as Feldan Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- RedHill Biopharma Ltd raised $2.7M (Seed) on July 21, 2023.
- Septerna raised $73M on June 28, 2023.
- Upstream Bio raised $200M (Series B) on June 8, 2023.
- Ray Therapeutics raised $14M on May 15, 2023.
- Laplace Interventional raised an undisclosed amount (Series B) on July 25, 2023.
- PaceMate raised an undisclosed amount (Corporate Round) on July 25, 2023.
Who to call at Feldan Therapeutics, and when
A new round usually means Feldan Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Feldan Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Feldan Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Feldan Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Feldan Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansFeldan Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.